Additionally, cholesterol metabolism is altered in RTT patients (Segatto et al., 2014), and limiting cholesterol biosynthesis alleviated RTT symptoms and increased the survival of mecp2-null mice (Buchovecky et al., 2013). The gene discussed is MECP2; the disease is Rett syndrome.